An international team of researchers led by the University of California San Diego has developed a new strategy to enhance pharmaceutical production in Chinese hamster ovary (CHO) cells, which are commonly used to manufacture protein-based drugs for treating cancer, autoimmune diseases and much more.
Bristol Myers cell therapy manufacturing site gets thumbs-up from FDA
A new Bristol Myers Squibb cell manufacturing site that is expected to make the CAR-T therapy Breyanzi has received FDA approval to start production. The
June 9, 2023